BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT.
Piras IS, Angius A, Andreani M, Testi M, Lucarelli G, Floris M, Marktel S, Ciceri F, La Nasa G, Fleischhauer K, et al. Bone Marrow Transplant. 2014 Nov; 49(11):1400-1404. Epub 2014 Aug 11.